Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Cost of Revenue: 2011-2024

Historic Cost of Revenue for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $38.0 million.

  • Niagen Bioscience's Cost of Revenue rose 29.10% to $12.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.0 million, marking a year-over-year increase of 27.40%. This contributed to the annual value of $38.0 million for FY2024, which is 15.92% up from last year.
  • Latest data reveals that Niagen Bioscience reported Cost of Revenue of $38.0 million as of FY2024, which was up 15.92% from $32.8 million recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Cost of Revenue registered a high of $38.0 million during FY2024, and its lowest value of $24.0 million during FY2020.
  • Moreover, its 3-year median value for Cost of Revenue was $32.8 million (2023), whereas its average is $33.4 million.
  • Data for Niagen Bioscience's Cost of Revenue shows a peak YoY climbed of 18.22% (in 2021) over the last 5 years.
  • Niagen Bioscience's Cost of Revenue (Yearly) stood at $24.0 million in 2020, then rose by 18.22% to $28.4 million in 2021, then increased by 3.18% to $29.3 million in 2022, then climbed by 12.09% to $32.8 million in 2023, then increased by 15.92% to $38.0 million in 2024.